Cheng‐Bei Zhou

979 total citations · 2 hit papers
12 papers, 479 citations indexed

About

Cheng‐Bei Zhou is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng‐Bei Zhou has authored 12 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng‐Bei Zhou's work include Gut microbiota and health (4 papers), Colorectal Cancer Screening and Detection (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Cheng‐Bei Zhou is often cited by papers focused on Gut microbiota and health (4 papers), Colorectal Cancer Screening and Detection (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Cheng‐Bei Zhou collaborates with scholars based in China, Russia and United States. Cheng‐Bei Zhou's co-authors include Jing‐Yuan Fang, Yilu Zhou, Zi‐Ran Kang, Xiao-Xu Leng, Lu Zhang, Linhong Song, Ni Wang, Yile Xie, Jilin Wang and Yingxuan Chen and has published in prestigious journals such as British Journal of Cancer, Cell Death and Disease and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Cheng‐Bei Zhou

11 papers receiving 472 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota in Cancer Immune Response and Immunotherapy

2021 220 citations Cheng‐Bei Zhou, Yilu Zhou et al. Trends in cancer profile →
Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway

2024 48 citations Ni Wang, Lu Zhang et al. Gut Microbes profile →

Peers

Cheng‐Bei Zhou

MB

ONCOL

PRM

IMMUN

CR

Lingfeng Fu Japan

Hu Han China

Xinyu Shao China

Handong Jiang China

Yajuan Zheng China

Ji Lv China

Yulin Qin China

Zhujiang Dai China

Linglong Peng China

Nassim Bouznad Germany

Lingfeng Fu Japan

Cheng‐Bei Zhou

328 ×1.0

MB

113 ×0.7

ONCOL

49 ×0.6

PRM

82 ×1.0

IMMUN

77 ×1.2

CR

Citations per year, relative to Cheng‐Bei Zhou Cheng‐Bei Zhou (= 1×) peers Lingfeng Fu

Countries citing papers authored by Cheng‐Bei Zhou

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Bei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Bei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Bei Zhou more than expected).

Fields of papers citing papers by Cheng‐Bei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Bei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Bei Zhou. The network helps show where Cheng‐Bei Zhou may publish in the future.

Co-authorship network of co-authors of Cheng‐Bei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Bei Zhou. A scholar is included among the top collaborators of Cheng‐Bei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Bei Zhou. Cheng‐Bei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Deng, Jiawen, Xinyue Ma, Chunqi Zhu, et al.. (2025). Derivation and validation of lifestyle-based and microbiota-based models for colorectal adenoma risk evaluation and self-prediction. BMJ Open Gastroenterology. 12(1). e001597–e001597. 2 indexed citations

2.

Liu, Xu, Danhua Xu, Cheng‐Bei Zhou, et al.. (2024). Association of PD-1 + Treg/PD-1 + CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatment. Journal of Translational Medicine. 22(1). 1152–1152.

3.

Zhou, Cheng‐Bei, et al.. (2024). The effects of pks⁺Escherichia coli and bile acid in colorectal tumorigenesis among people with cholelithiasis or cholecystectomy. Journal of Gastroenterology and Hepatology. 39(5). 868–879. 3 indexed citations

4.

Wang, Ni, Lu Zhang, Xiao-Xu Leng, et al.. (2024). Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway. Gut Microbes. 16(1). 2333790–2333790. 48 indexed citations breakdown →

5.

Qian, Yun, Zi‐Ran Kang, Huimin Chen, et al.. (2023). Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula. Chinese Medical Journal. 136(22). 2722–2731. 14 indexed citations

6.

Deng, Jiawen, Cheng‐Bei Zhou, Chunqi Zhu, et al.. (2023). Noninvasive predictive models based on lifestyle analysis and risk factors for early‐onset colorectal cancer. Journal of Gastroenterology and Hepatology. 38(10). 1768–1777. 12 indexed citations

7.

Yu, TaChung, Xiaowen Huang, Jilin Wang, et al.. (2022). Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness. British Journal of Cancer. 128(2). 363–374. 21 indexed citations

8.

Wang, Yingchao, Xiao-Xu Leng, Cheng‐Bei Zhou, et al.. (2022). Non-enzymatic role of SOD1 in intestinal stem cell growth. Cell Death and Disease. 13(10). 882–882. 8 indexed citations

9.

Zhou, Cheng‐Bei, Yilu Zhou, & Jing‐Yuan Fang. (2021). Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends in cancer. 7(7). 647–660. 220 indexed citations breakdown →

10.

Xie, Yuanhong, Tianhui Zou, Yun Qian, et al.. (2021). Fecal Fusobacterium nucleatum as a predictor for metachronous colorectal adenoma after endoscopic polypectomy. Journal of Gastroenterology and Hepatology. 36(10). 2841–2849. 11 indexed citations

11.

Zhou, Cheng‐Bei & Jing‐Yuan Fang. (2019). The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1872(1). 1–10. 119 indexed citations

12.

Zhou, Cheng‐Bei & Jing‐Yuan Fang. (2018). The regulation of host cellular and gut microbial metabolism in the development and prevention of colorectal cancer. Critical Reviews in Microbiology. 44(4). 436–454. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact